[Federal Register Volume 81, Number 102 (Thursday, May 26, 2016)]
[Notices]
[Pages 33540-33541]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-12472]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Office of the Secretary, Office of the Assistant Secretary for 
Health, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held of the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (Advisory Council). 
The meeting will be open to the public; a public comment session will 
be held during the meeting. Pre-registration is required for members of 
the public who wish to attend the meeting and who wish to participate 
in the public comment session. Individuals who wish to attend the 
meeting and/or send in their public comment via email should send an 
email to [email protected]. Registration information is available on the Web 
site http://www.hhs.gov/ash/carb/ and must be completed by June 18, 
2016; all in-person attendees must pre-register by this date. 
Additional information about registering for the meeting and providing 
public comment can be obtained at http://www.hhs.gov/ash/carb/ on the 
Meetings page.

DATES: The meeting is scheduled to be held on June 21, 2016, from 10:00 
a.m. to 5:00 p.m. ET, and June 22, 2016, from 9:00 a.m. to 4:00 p.m. ET 
(times are tentative and subject to change). The confirmed times and 
agenda items for the meeting will be posted on the Web site for the 
Advisory Council at http://www.hhs.gov/ash/carb/ when this information 
becomes available. Pre-registration for attending the meeting in person 
is required to be completed no later than June 18, 2016; public 
attendance at the meeting is limited to the available space.

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Great Hall, 200 Independence Avenue SW., Washington, 
DC 20201.
    The meeting also can be accessed through a live webcast on the day 
of the meeting. For more information, visit http://www.hhs.gov/ash/carb/.

FOR FURTHER INFORMATION CONTACT: Bruce Gellin, Designated Federal 
Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, Room 715H, Hubert H. Humphrey 
Building, 200 Independence Avenue SW., Washington, DC 20201. Phone: 
(202) 260-6638; email: [email protected].

SUPPLEMENTARY INFORMATION: Under Executive Order 13676, dated September 
18, 2014, authority was given to the Secretary of HHS to establish the 
Advisory Council, in consultation with the Secretaries of Defense and 
Agriculture. Activities of the Advisory Council are governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. App.), which sets 
forth standards for the formation and use of federal advisory 
committees.
    The Advisory Council will provide advice, information, and 
recommendations to the Secretary of HHS regarding programs and policies 
intended to support and evaluate the implementation of Executive Order 
13676, including the National Strategy for Combating Antibiotic-
Resistant Bacteria and the National Action Plan for Combating 
Antibiotic-Resistant Bacteria. The Advisory Council shall function 
solely for advisory purposes.
    In carrying out its mission, the Advisory Council will provide 
advice, information, and recommendations to the Secretary regarding 
programs and policies intended to preserve the effectiveness of 
antibiotics by optimizing their use; advance research to develop 
improved methods for combating antibiotic resistance and conducting 
antibiotic stewardship; strengthen surveillance of antibiotic-resistant 
bacterial infections; prevent the transmission of antibiotic-resistant 
bacterial infections; advance the development of rapid point-of-care 
and agricultural diagnostics; further research on new treatments for 
bacterial infections; develop alternatives to antibiotics for 
agricultural purposes; maximize the dissemination of up-to-date 
information on the appropriate and proper use of antibiotics to the 
general public and human and animal healthcare providers; and improve 
international coordination of efforts to combat antibiotic resistance.
    On June 21, the public meeting will be dedicated to presentations 
from federal and non-federal stakeholders surrounding topic areas 
related to incentives for the development of vaccines, diagnostics, and 
therapeutics. On June 22, the meeting will focus on the topic of the 
environment and antibiotic-resistance, in addition to a presentation 
regarding the new guidance from the Food and Drug Administration for 
Industry #213, ``New Animal Drugs and New Animal Drug Combination 
Products Administered in or on Medicated Feed or Drinking Water of 
Food-Producing Animals: Recommendations for Drug Sponsors for 
Voluntarily Aligning Product Use Conditions With Guidance for Industry 
#209.'' The meeting agenda will be posted on the Advisory Council Web 
site at http://www.hhs.gov/ash/carb/ when it has been finalized. All 
agenda items are tentative and subject to change.
    Public attendance at the meeting is limited to the available space. 
Individuals who plan to attend and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify the Designated Federal Officer at the address/telephone number 
listed above at least one week prior to the meeting. For those unable 
to attend in person, a live webcast will be available. More information 
on registration and accessing the webcast can be found at http://www.hhs.gov/ash/carb/.
    Members of the public will have the opportunity to provide comments 
prior to the Advisory Council meeting by emailing [email protected]. Public

[[Page 33541]]

comments should be sent in by midnight June 15, 2016, and should be 
limited to no more than one page. All public comments received prior to 
June 15, 2016, will be provided to Advisory Council members; comments 
are limited to two minutes per speaker.

    Dated: May 18, 2016.
Bruce Gellin,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Deputy Assistant Secretary for Health.
[FR Doc. 2016-12472 Filed 5-25-16; 8:45 am]
BILLING CODE 4150-44-P